Shoelson S E, Marshall S, Horikoshi H, Kolterman O G, Rubenstein A H, Olefsky J M
J Clin Endocrinol Metab. 1986 Jul;63(1):56-61. doi: 10.1210/jcem-63-1-56.
An insulin-requiring diabetic patient with intermittent periods of increased insulin requirements and insulin resistance was studied. The patient was found to have high titers of antiinsulin antibodies; subfractionation of the patient's serum revealed several populations of antiinsulin antibodies with differing affinities and titers for insulin. The ability of one of the insulin antibody fractions to bind [125I]iodoinsulin was markedly inhibited by the patient's serum (insulin depleted) and by purified total immunoglobulin G from which antiinsulin antibodies and insulin were removed. These findings suggested an antiidiotypic antibody in the patient's immunoglobulin G fraction reacting specifically with the antiinsulin antibody subfraction. Finally, the patient's serum contained an antiinsulin receptor antibody, as demonstrated by the ability of serum to specifically immunoprecipitate covalently labeled soluble insulin receptors. In conclusion, these results suggest that this patient generated a widespread polyclonal response to insulin, with the development of several populations of antiinsulin antibodies. An antiidiotypic antibody to a specific insulin antibody subfraction was present in the patient's serum which we believe had structural similarity to the binding site of the insulin molecule, accounting for the reactivity of the antiidiotypic antibody with the insulin receptor.
对一名胰岛素依赖型糖尿病患者进行了研究,该患者胰岛素需求量和胰岛素抵抗存在间歇性增加。发现该患者具有高滴度的抗胰岛素抗体;对患者血清进行亚组分分析显示存在几种不同亲和力和滴度的抗胰岛素抗体群体。患者血清(去除胰岛素)和去除抗胰岛素抗体及胰岛素的纯化总免疫球蛋白G能显著抑制其中一种胰岛素抗体组分与[125I]碘胰岛素结合的能力。这些发现提示患者免疫球蛋白G组分中存在一种抗独特型抗体,它与抗胰岛素抗体亚组分发生特异性反应。最后,患者血清含有抗胰岛素受体抗体,血清能够特异性免疫沉淀共价标记的可溶性胰岛素受体即证明了这一点。总之,这些结果提示该患者对胰岛素产生了广泛的多克隆反应,出现了几种抗胰岛素抗体群体。患者血清中存在针对特定抗胰岛素抗体亚组分的抗独特型抗体,我们认为其在结构上与胰岛素分子的结合位点相似,这就解释了抗独特型抗体与胰岛素受体的反应性。